Flagstar Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Flagstar Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,303	Closed	-$152K	–	199
2022 Q3	$152K	Buy	+1,303	New	+$162K	0.06%	160
2021 Q4	–	Sell	-916	Closed	-$148K	–	171
2021 Q3	$148K	Buy	+916	New	+$154K	0.05%	130

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Flagstar Advisors's IBB Position: Q4 2022 in Review

Flagstar Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 1,303 shares — an estimated $152K sold.

Flagstar Advisors first reported a position in IBB in Q3 2021 and held it in 2 quarters. The position peaked at $152K in Q3 2022. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Flagstar Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
Flagstar Advisors sold 1,303 iShares Biotechnology ETF shares in Q4 2022, an estimated $152K.
Flagstar Advisors first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 2 quarters.
Flagstar Advisors's iShares Biotechnology ETF position peaked at $152K in Q3 2022.
902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Flagstar Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.